PortfoliosLab logoPortfoliosLab logo
Sera Prognostics, Inc. (SERA)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US81749D1072
CUSIP
81749D107
IPO Date
Jul 15, 2021

Highlights

Market Cap
$101.46M
Enterprise Value
$99.86M
EPS (TTM)
-$0.64
Total Revenue (TTM)
$81.00K
Gross Profit (TTM)
-$83.00K
EBITDA (TTM)
-$32.30M
Year Range
$1.37 - $4.09
Target Price
$5.00
ROA (TTM)
-31.32%
ROE (TTM)
-42.34%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sera Prognostics, Inc.

Often compared with SERA:
SERA vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Sera Prognostics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Sera Prognostics, Inc. (SERA) has returned -31.19% so far this year and -44.84% over the past 12 months.


Sera Prognostics, Inc.

1D
5.73%
1M
-11.35%
YTD
-31.19%
6M
-33.66%
1Y
-44.84%
3Y*
-19.07%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 15, 2021, SERA's average daily return is +0.10%, while the average monthly return is +2.15%. At this rate, your investment would double in approximately 2.7 years.

Historically, 40% of months were positive and 60% were negative. The best month was Dec 2023 with a return of +208.3%, while the worst month was May 2025 at -46.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, SERA closed higher 44% of trading days. The best single day was Dec 6, 2023 with a return of +161.4%, while the worst single day was Jun 30, 2025 at -32.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-6.44%-17.03%-11.35%-31.19%
2025-20.52%-34.47%-13.21%-20.11%-46.94%77.56%0.36%16.19%-5.26%7.19%1.52%-11.41%-63.76%
202417.06%27.43%2.02%28.46%-23.01%-34.22%40.03%-11.34%6.12%-1.41%-12.35%20.77%36.12%
202320.63%140.79%4.64%-12.53%-3.58%2.01%-11.08%-39.25%4.49%-9.14%14.79%208.25%374.60%
2022-1.75%-20.59%-29.29%-39.31%-39.57%17.99%39.02%-7.89%-23.81%-3.75%-12.99%-5.97%-81.66%
2021-5.63%-11.40%11.66%-7.02%2.61%-35.19%-42.27%

Benchmark Metrics

Sera Prognostics, Inc. has an annualized alpha of 17.59%, beta of 0.86, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since July 16, 2021.

  • This stock participated in 137.23% of S&P 500 Index downside but only -25.93% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
17.59%
Beta
0.86
0.01
Upside Capture
-25.93%
Downside Capture
137.23%

Return for Risk

Risk / Return Rank

SERA ranks 25 for risk / return — below 25% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


SERA Risk / Return Rank: 2525
Overall Rank
SERA Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
SERA Sortino Ratio Rank: 3434
Sortino Ratio Rank
SERA Omega Ratio Rank: 3333
Omega Ratio Rank
SERA Calmar Ratio Rank: 1515
Calmar Ratio Rank
SERA Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Sera Prognostics, Inc. (SERA) and compare them to a chosen benchmark (S&P 500 Index).


SERABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.33

0.90

-1.22

Sortino ratio

Return per unit of downside risk

0.22

1.39

-1.17

Omega ratio

Gain probability vs. loss probability

1.03

1.21

-0.19

Calmar ratio

Return relative to maximum drawdown

-0.72

1.40

-2.12

Martin ratio

Return relative to average drawdown

-1.28

6.61

-7.88

Explore SERA risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Sera Prognostics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Sera Prognostics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sera Prognostics, Inc. was 91.10%, occurring on Dec 28, 2022. The portfolio has not yet recovered.

The current Sera Prognostics, Inc. drawdown is 84.43%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.1%Aug 10, 2021350Dec 28, 2022
-23.11%Jul 16, 20218Jul 27, 20214Aug 2, 202112
-8%Aug 3, 20211Aug 3, 20212Aug 5, 20213

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sera Prognostics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Sera Prognostics, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SERA relative to other companies in the Diagnostics & Research industry. Currently, SERA has a P/S ratio of 1,241.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SERA in comparison with other companies in the Diagnostics & Research industry. Currently, SERA has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items